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ABSTRACT Two members of the Shaker K+ channel
family designated ShA2 and ShD2 were characterized in the
Xenopus oocyte expression system. The predicted amino acid
sequences ofShA2 and ShD2 differ only in the amino terminus,
which is located intracellularly according to the present topo-
logical model ofK+ channels. The differing amino termini have
profound effects on the electrophysiological and pharmacolog-
ical properties of the K+ channel. Most markedly, the nature
of the amino terminus determines whether the K+ channel
mediates rapidly inactivating or noninactivating K+ currents.
It also affects the 4-aminopyridine, tetraethylammonium, and
charybdotoxin sensitivities of the K+ channels. These results
suggest that the amino terminus of Shaker proteins affects K+
channel structures on both sides of the membrane.
Voltage-gated K+ channels represent an extraordinarily di-
verse class of ionic channels that are essential for setting the
membrane resting potential and the duration of action poten-
tials and for the generation and tuning offiring patterns (1, 2).
Several invertebrate and vertebrate voltage-gated K+ chan-
nels have been cloned (3-14). Their primary sequences are
remarkably similar despite the functional diversity of K+
channels. Apparently, voltage-gated K+ channels with dif-
ferent electrophysiological and pharmacological properties
have been derived from a common ancestor (11, 12). Com-
parison of the sequences and the electrophysiological prop-
erties of cloned K+ channels suggests that minor sequence
alterations sufficed to build a variety of diverse voltage-gated
K+ channels.
The cloning and functional characterization of the Dro-
sophila Shaker (Sh) K+ channel family revealed variant
transient A-type K+ channels with distinct activation and
inactivation rates (15-17). The K+ channels are formed by
proteins that share a common core region containing six
potentially membrane-spanning segments flanked by diverse
amino and carboxyl termini. It has been proposed that the six
transmembrane segments are oriented in a pseudosymmetric
fashion across the membrane and that the amino and car-
boxyl termini are located on the intracellular side of the
membrane (4). Given the proposed topology of K+ channels
in the membrane, the amino-terminal sequence of Sh protein
might be operative only at the intracellular side of the
membrane. In the present report, we show that a particular
variation of the amino-terminal sequence in the Sh protein
family affects the electrophysiological as well as the'phar-
macological properties of Sh K+ channels. This variation
transforms rapidly inactivating Sh K+ channels into noninac-
tivating ones. Also, the sensitivity toward channel blockers
and toxins acting from the outside is altered by 1-2 orders of
magnitude. These results suggest that the amino-terminal
sequences of Sh proteins affect structures of the Sh K+
channels with functional roles on both sides of the mem-
brane.
MATERIALS AND METHODS
RNA Synthesis and Injection into Oocytes. A full-length
cDNA clone (ShcDNA3) encoding ShA2 has been described
(4). Since a full-length cDNA clone encoding ShD2 has not
been isolated to date, overlapping cDNA clones encoding
partial sequences were used to construct templates for cRNA
synthesis. The pAS18 expression vector (18) was used for
expression. We constructed pAS18-,3E, a clone that con-
tained the core region (exons 7-15 in ref. 4) and the carboxyl
terminus (exons 16-18 in ref. 4) shared by all members of the
class 2 Sh family (see Fig. 1). This clone was obtained by
ligating the Xba I-EcoRI fragment of cDNA,3 (nucleotides
+699 to +2151 in ref. 4) with Xba I/Sma I-cut pAS18 after
the EcoRI site of the Xba I-EcoRI fragment of cDNAf was
filled in with DNA polymerase I (Klenow). Various cDNAs
encoding the different amino termini of Sh proteins were
ligated with HindIII/Xba I-cut pAS18-,3E DNA. For this
purpose the HindIll site was filled in with DNA polymerase
I (Klenow). pAS18-A2 was obtained by ligating the HindIll!
Xba I-cut pAS18-,fE DNA with the EcoRI-Xba I fragment of
cDNAJ (nucleotides -270 to +699 in ref. 4) after filling in its
EcoRP site. pAS18-D2 was obtained by ligating the EcoRI!
Xba I-cut pAS18-13E DNA with the EcoRI-Xba I fragment of
cDNAO (nucleotides -73 to 600 in ref. 4) blunt-ended at its
EcoRI site. The resulting pAS18-A2' and pAS18-D2 clones
were verified by restriction enzyme digestions. pAS18-A2
and pAS18-D2 plasmid DNAs were linearized at the EcoRI
site before synthesis of ShA2 and ShD2 cRNAs. cRNA
synthesis was as described (18, 19). cRNA (0.5 mg/ml) was
injected into oocytes of Xenopus laevis (stage Vb/VI) in
portions of 50 nl per oocyte. The oocytes were incubated in
Barth's medium at 19'C and prepared for electrophysiolog-
ical measurements (20). The expression of Sh K+ channels
was detectable in nearly every oocyte 2 days after injection,
with a maximum at days 4-7.
Current Recording and Data Analysis. The bath solution
was 115 mM NaCl/2.5 mM KCl/1.8 mM CaCl2/10 mM
Hepes, pH 7.2. In some experiments, Na+ was partially
replaced by K+ or by the blocking substances 4-aminopyri-
dine (4-AP) and tetraethylammonium chloride (TEA) (Sig-
ma). Dendrotoxin (DTX), mast cell degranulating peptide
(MCDP) (gifts from F. Dreyer and E. Habermann, Univer-
sitat Giessen, Giessen, F.R.G.), and charybdotoxin (CTX)
(gift from C. Miller, Brandeis University, Waltham, MA)
were added to the bath solution. Patches in the inside-out
configuration were excised into 120 mM KCl/1.8 mM
EGTA-KOH/10 mM Hepes, pH 7.2.
Abbreviations: 4-AP, 4-aminopyridine; TEA, tetraethylammonium;
DTX, dendrotoxin; MCDP, mast cell degranulating peptide; CTX,
charybdotoxin.
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A two-microelectrode voltage clamp was used to test for
the action of the toxins and to determine the whole-cell K+
current of each oocyte prior to patch current recording. All
values given are means ± SD. In -20% of the oocytes
injected the current was >10 ,4A for a test pulse from -80 to
0 mV. This indicated that the channel density was high
enough for recording from macropatches. Pipettes for mac-
ropatches were made from aluminum silicate glass with a tip
diameter of 4-6 a.m (21). They were filled with the normal
bath solution for cell-attached recording, giving a resistance
of 0.5-1 Mfl. The intracellular potential was simultaneously
measured by a microelectrode to determine the effective
transmembrane potential across the patch. The K+ channel
density was not homogeneous, and therefore the oocyte had
to be patched on several different places before an area of
high current density was found. Stimulation and sampling
were done as described (21). To determine the steady-state
activation parameters, the function G = Gm,,/{1 + exp[(Vi/2
- V)la]} was fitted to the conductance values (G) at each
potential. These conductances were obtained by dividing the
peak current by the driving force, assuming a reversal
potential of -100 mV in the cell-attached configuration and
a calculated reversal of -98 mV in the inside-out configura-
tion. Steady-state inactivation parameters were measured for
the only channel inactivating in the millisecond time scale,
ShA2, by using prepulses lasting 1 s. The data were analyzed
by fitting the function I/lmac = 1/{1 + exp[(V - Vil2)/a]} to
the data points.
Pipettes for single-channel recording were made from
borosilicate glass and had resistances of 3-5 Mfl when filled
with bath solution. The single-channel current records were
stored on video tape and analyzed by an interactive semi-
automatic procedure. Distributions of single-channel current
amplitudes were fitted assuming Gaussian distribution.
RESULTS
The Sh locus encodes a large transcription unit that is spliced
into multiple mature transcripts (3, 4, 7). These transcripts
are translated into a family of K+ channel-forming proteins
that have five variant amino termini and two different car-
boxyl termini (Fig. 1). The nomenclature of Sh K+ channels
poses potential problems. Historically, it is based on isolated
cDNA clones, which have been characterized in three dif-
ferent laboratories (3, 4, 7). We have proposed a systematic
nomenclature that designates predicted Sh K+ channel-
forming proteins and not cDNA clones (22). The nomencla-








been shown to mediate K+ currents. The variant amino
termini are designated A, B, D, G, and H according to the
corresponding cDNAs (see legend to Fig. 1). The two alter-
native carboxyl termini are designated by 1 or 2; e.g., ShAl
protein contains amino terminus A and carboxyl terminus 1.
The ability ofShD proteins to form K+ channels had not been
studied yet. We became interested in ShD proteins because
polymerase chain reaction and Northern analysis of ShD
transcripts indicated that ShD transcripts are preferentially
expressed in Drosophila body tissue (data not shown),
whereas other members of the Sh family are preferentially
expressed in the nervous system (4). Also, the deduced ShD2
protein sequence had the highest homology with the deduced
sequence of rat RCK1 protein (12), which forms delayed
rectifier-type K+ channels in the Xenopus oocyte expression
system (10, 13, 19).
ShA2- and ShD2-Mediated Currents Differ in Activation and
Inactivation Kinetics. ShA2 channels mediate the most rap-
idly inactivating outward currents of the Sh K+ channel
family (refs. 16 and 17; Fig. 2). The 61 amino-terminal amino
acids of ShA2 are replaced by only 16 amino acids in ShD2
(4, 22). This replacement changes the activation and inacti-
vation kinetics of macroscopic currents produced by ShA2 or
ShD2 after injection of the respective cRNAs into Xenopus
oocytes. The rise-to-peak of the ShA2 current for a test pulse
from a holding potential of -80 mV to a test potential of 10
mV required 1.4 ± 0.5 ms (n = 9). ShA2 currents inactivated
rapidly with a time course that could be fitted with a single
exponential, but the currents did not fall to baseline at the end
of a 100-ms test pulse (Fig. 2a). A residual steady-state
current representing 8-15% (n = 10) of the transient peak
current was observed. It did not inactivate within the milli-
second time range.
The normalized conductance-voltage relation (Fig. 2b) of
the ShA2 ensemble currents, G/Gmax(V), indicates that they
start to activate at test potentials of -40 mV. The conduc-
tance was half-maximal in the range of test potentials of
-14.5 + 9.8 mV (Table 1) and saturated at test potentials of
+30 to +40 mV. The slope of the normalized conductance-
voltage relation is 13.2 mV/e-fold. The results were obtained
from macropatches by recording in the cell-attached config-
uration of the patch-clamp technique. They are similar to
results obtained with whole-cell current recordings after
injection of similar Sh transcripts (ShB/ShH4) into oocytes
(15-17). In inside-out patches the values for half-maximal
activation and its slope were -23.6 and 16.7 mV/e-fold,
respectively. Steady-state inactivation of the ShA2 currents
measured in the cell-attached mode was also similar to that
CARBOXYL
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FIG. 1. General structure of the family of Sh K+ channels. Boxes illustrate the various domains of Sh K+ channel-forming proteins. A
common core region is flanked by variable amino termini (A, B, D, G, H) and by one of two alternative carboxyl termini (22). Box lengths are
approximately to scale. Bar at lower right corresponds to 20 amino acids. All combinations between the core region and the amino and carboxyl
termini are possible (7, 22). The amino-terminal sequence derived from Sh cDNAa has been designated A, that of cDNA,8 (4) B, of cDNAy
(4) G, of cDNA8 (4) D, and of cDNA H37 (7) H, respectively. The suffix 1 or 2 designates the carboxyl terminus; e.g., ShA2 is a protein with
amino terminus A and carboxyl terminus 2. The expression of transient voltage-gated A-type currents was studied with ShAl, ShA2, ShB2,
ShC1, and ShH1 transcripts after injection into Xenopus oocytes. [Code for the nomenclature of other laboratories: ShAl = ShA (3, 16); ShA2
= ShB (3, 16) or ShH4 (7, 17); ShB2 = ShD (3, 16); ShC1 = ShC (3, 16); ShH1 = ShH37 (7, 17)].
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FIG. 2. (a) Families of outward currents in response to depolar-
izing voltage steps recorded from a macropatch in the cell-attached
configuration. Top ShA2; bottom ShD2. The traces are responses to
50-ms voltage steps from -80 to 80 mV in 10-mV increments from a
holding potential of -100 mV. Sampling interval was 60 As; filtering
was at 3 kHz (3 dB), low pass. (b) Plots of normalized conductance
(G/Gmax) versus test potential for ShA2 (n) and ShD2 (0) channels.
The conductance values were obtained by dividing the peak current
at a particular test potential by an assumed reversal potential of -100
mV (close to the potential where tail currents reverse). The contin-
uous lines are the results of nonlinear least-squares fits to the data.
The maximal conductance (Gmax) obtained by the fit was used to
normalize the data.
of ShB/ShH4 currents, both in voltage dependence and in
slope (Table 1). On excision of the patch, all electrophysio-
logical parameters measured shifted to the left on the voltage
axis. These shifts cannot be explained by changes injunction
potential, which were on the order of only a few millivolts.
In contrast to ShA2 currents, ShD2 currents did not
inactivate rapidly at most test potentials studied (Fig. 2a).
Only at more positive test potentials, where the noninacti-
vating ShD2 steady-state current saturates, did a rapidly
inactivating component become apparent. At test potentials
of +80 mV, the rapidly inactivating component represented
15 10% (n = 5) of the peak current. The appearance of this
rapidly inactivating component was accompanied by a de-
crease in steady-state current. The G/Gmax(V) relation of
ShD2 indicates that channels began to activate at test poten-
tials of -40 mV (Fig. 2b), like ShA2 currents. However, the
conductance was half-maximal at -25.6 7 mV (Table 1),
-10 mV more negative than that of ShA2 currents. The
Table 1. Electrophysiological parameters of ShA2 and ShD2
channels expressed in Xenopus oocytes
Activation
cRNA Method V1/2, mV a, mV n Vi/2, mV a, mV n
ShA2 CA -14.5 + 9.81 13.2 9 -34.1 ± 2.7 6.4 2
10 -23.6 16.7 1 -50.3 ± 2.7 6.5 3
ShD2 CA -25.6 + 6.97 11.4 5
10 -36.4 8.33 1
CA, cell-attached patches; 10, inside-out patches; V1/2, potential of
half-activation or inactivation; a, potential change needed to obtain
an e-fold change in the conductance- or inactivation-voltage depen-
dencies at Vi/2.
conductance saturated at 0 to +10 mV. The slope of the
normalized conductance-voltage relations is 11.4 mV/e-fold.
The ShD2 currents needed 2.5 + 0.6 ms (n = 5) to rise to peak
following a test pulse from a holding potential of -80 mV to
a potential of 10 mV. This difference in activation rates could
mean that ShD2 currents activate more slowly than ShA2
currents. However, as shown in the Discussion, variations in
inactivation rates per se are able to reproduce these changes
in rise times.
ShA2 and ShD2 Channels Have Similar Conductances and
Different Open Durations. Examples of single-channel cur-
rents recorded in inside-out patches from oocytes injected
with ShA2 or ShD2 cRNA are shown in Fig. 3. With a driving
force of 100 mV, both unitary currents showed a Gaussian
distribution around a mean of -0.8 pA, giving an apparent
single-channel conductance of -8 pS. This agrees with data
for other Sh K+ channels (17, 24), indicating that the amino
terminus does not greatly affect the single-channel conduc-
tance of Sh K+ channels. Further, the selectivity of the K+
channels, as determined from tail-current analysis, was not
altered (data not shown). Open-duration histograms of both
channels at 0 mV are well fitted by single-exponential prob-
ability density functions, with means of 0.7 ms in the case of
ShA2 channels and of 3.0 ms in the case of ShD2 channels.
ShA2 and ShD2 Channels Have Different Pharmacological
Properties. The proposed membrane topology of voltage-
gated ion channels places the amino terminus on the intra-
cellular side of the membrane. Therefore, the differences in
the gating behavior of ShA2 and ShD2 channels might
indicate a different interaction of the A or D amino terminus
with the inactivation gate of the Sh K+ channel located
intracellularly (25). The structural differences between ShA2
and ShD2 channels could be purely local. Alternatively, the
different amino termini could influence the overall structure
of Sh K+ channels. This proposition was tested with K+
channel blockers. Because of its positive charge and polar
nature, CTX is membrane-impermeant and acts from the
extracellular side. The affinity ofCTX for its extracellular K+
channel binding site should not be influenced if the structural
differences between ShA2 and ShD2 channels were confined
to the intracellular side of the channel. However, the ampli-
tudes of currents measured in oocytes injected with ShA2 or
ShD2 cRNA were reduced by different concentrations of
CTX (Table 2). ShA2 channels were very sensitive to CTX
(IC50 = 4 nM) in agreement with previously published data
(26). In contrast, ShD2 channels were relatively insensitive to
CTX (IC50 = 105 nM), more like native Sh K+ channels (24).
The different CTX sensitivities of ShA2 and ShD2 channels
indicate that the two channels differ in extracellular struc-
ture. This observation is further supported by the different
sensitivities of ShA2 and ShD2 channels to other K+ channel
blockers that probably also act from the extracellular side
(Table 2). ShA2 channels were 5 times more sensitive to TEA
(IC50 = 18 mM) than ShD2 channels (IC50 = 92 mM). On the
other hand, ShA2 channels were only 1/10th as sensitive to
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FIG. 3. (a and b) Single ShA2 (a) and ShD2 (b) channels recorded in an inside-out patch from oocytes injected with ShA2 or ShD2 cRNA,
respectively. The data have been transformed for improved display according to ref. 23. Representative sweeps containing channel openings
during a prolonged depolarization to 0 mV are shown. The lower part of each trace represents the closed current level. (c and d) Open-duration
histogram at 0 mV for ShA2 channels, (c), giving a mean open time of 0.7 ms, and for ShD2 channels (d), giving a mean open time of 3.0 ins.
These different pharmacological properties of ShA2 and
ShD2 channels indicate that the replacement of the A termi-
nus by the D terminus in Sh K+ channels produces a
conformational change that affects several binding sites for
K+ channel blockers as well as the gating behavior of the K+
channels. Finally, it should be noted that both ShA2 and
ShD2 channels were insensitive to DTX and the MCDP
(Table 2), in strong contrast to most members of the RCK K+
channel family (10).
DISCUSSION
Electrophysiological data on voltage-dependent K+ channels
indicate that the activation/inactivation gate(s) of these chan-
nels is located on the intracellular side of the membrane and
the toxin binding sites on the extracellular side (2, 26). Tables
1 and 2 show that ShA2 channels differ from ShD2 channels
both electrophysiologically and pharmacologically. When all
Table 2. Pharmacological characteristics of ShA2 and ShD2
channels expressed in Xenopus oocytes
IC50 value
4-AP, TEA, DTX, MCDP, CTX,
cRNA mM mM nM nM nM
ShA2 5.5 17.8 >>200 >>2000 4.0
ShD2 0.5 92 >>200 >>1000 105.0
IC50 values (concentrations for 50% inhibition of peak current)
were measured at a test potential of +20 mV; all experiments were
made under two-electrode voltage clamp. Each value is the average
of at least two independent measurements.
the observed differences are considered, the K+ channel
structures involved in channel gating as well as the different
binding sites for channel blockers ought to be different
between ShA2 and ShD2 channels. It should be realized that
the electrophysiological and pharmacological changes intro-
duced by the variant amino termini are neither necessarily
nor specifically linked to these sequences. It is known that a
local structural change can trigger a change in the quaternary
protein structure (27). The available evidence suggests that
Sh K+ channels are multimeric proteins and consequently
have a quaternary structure (4, 28). We propose, therefore,
that the local change in the amino-terminal sequence of a Sh
channel alters the quaternary structure of the K+ channel and
thereby affects its electrophysiological and pharmacological
properties. In this context one has to consider the possibility
that changes in inactivation properties might change K+-site
occupancy and thereby change toxin equilibrium constants
on the extracellular side [a similar effect has been observed
in Ca2l-activated K+ channels for CTX binding (29)]. The
altered quaternary structure does not, however, affect the
single-channel conductance and ion selectivity, which are
properties of the pore.
The different gating properties of ShA2 and ShD2 channels




in which C is the last, short-duration closed state, 0 a
short-duration open state, and I a long-duration inactivated
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times will be a single exponential with a mean duration of 1/(8
+ K), and the level of steady-state inactivation will depend on
the ratio between K and A. Since the experimental data
indicate that both 8 + K and the ratio between K and A vary
between ShA2 and ShD2, the most economical interpretation
of our results can be obtained by assuming that the amino
termini influence mainly the rate K. The rapidly inactivating
currents of ShA2 channels and their short mean open times
indicate that K is large. On the other hand, ShD2 channels
mediate noninactivating currents with longer mean open
times, indicating that K is small. In fact, the current records
obtained at 0 mV could be simulated by assuming the
following rates (ms-1): y = 0.40, 8 = 0.32, and A = 0.05 for
both Sh channels, and either K = 1.11 for ShA2 or K = 0.013
for ShD2. These parameters give the experimentally deter-
mined mean open durations of 0.7 ms for ShA2 and 3.0 ms for
ShD2 and are also able to reproduce quantitatively the
activation and inactivation time constants as well as the
steady-state inactivation levels.
Intermediate values of K emulated currents with various
degrees of rapidly inactivating as well as noninactivating
components, similar to the ones observed in expression
studies with ShB and ShG channels (16, 17) or in variants
generated by in vitro mutagenesis (30). In experiments with
tissue-derived mRNA or with intact cells, the presence of
various inactivating components would be explained by the
probable presence of more than one channel type. In the
present case, however, only one channel species is present,
and the kinetic model given above is able to emulate the
various inactivation kinetics. In this context it is interesting
to compare the inactivation behavior of Sh K+ channel
variants with that of the Na' channel. This channel consists
of four domains, each of which is homologous to the K+
channel subunit (4). Manipulations of the region between
repeats III and IV drastically influence the inactivation
properties of the Na' channel (31). Antibodies directed
against this region also selectively affect inactivation (32).
The sequence between domains III and IV is formally equiv-
alent to the carboxyl- and amino-terminal sequences of one
K+ channel subunit. This can be taken as an indication that
these regions are able to modulate inactivation in both types
of channels.
Sh K+ channels expressed in the oocyte expression system
are similar to native Sh K+ channels (24) in many respects-
e.g., voltage dependence of activation/inactivation and sin-
gle-channel conductance-but they differ in some proper-
ties-e.g., open duration times of single channels and sensi-
tivity to CTX. Native Sh K+ channels are insensitive to CTX,
whereas Sh K+ channels expressed in Xenopus oocytes are
very sensitive to CTX (ref. 33 and Table 2). The present study
shows that the CTX sensitivity of homomultimeric Sh K+
channels is variable. At 50 nM CTX, currents mediated by
ShA2 or ShD2 channels are either blocked completely or not
blocked at all, respectively. This CTX concentration was
used previously to study the CTX sensitivity of native Sh K+
channels (24). The different pharmacological properties of
ShA2 and ShD2 proteins can be reconciled by assuming more
than one open state with different affinities for the various
channel blockers. As a consequence, variant dwell times in
the various states would give rise to diverse inhibition doses.
However, that the open-time distribution is well fitted by a
single exponential is inconsistent with this hypothesis. Alter-
natively, the variant pharmacological properties of ShA2 and
ShD2 could arise from parts of the amino terminus located
extracellularly. The absence of a signal peptide mediating
membrane translocation of the amino terminus in all voltage-
dependent channels sequenced so far, as well as topological
constraints on the homologous Na' channel (31, 32), argues
against this hypothesis.
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